Aurélien Dupré1, Hassan Z Malik2, Robert P Jones3, Rafael Diaz-Nieto2, Stephen W Fenwick2, Graeme J Poston2. 1. Liverpool Hepatobiliary Centre, Aintree University Hospital, Longmoor Lane, Liverpool, L9 7AL, UK; Centre Léon Bérard, Department of Surgical Oncology, Lyon, F-69008, France. Electronic address: aurelien.dupre@lyon.unicancer.fr. 2. Liverpool Hepatobiliary Centre, Aintree University Hospital, Longmoor Lane, Liverpool, L9 7AL, UK. 3. Liverpool Hepatobiliary Centre, Aintree University Hospital, Longmoor Lane, Liverpool, L9 7AL, UK; School of Cancer Studies, Institute of Translational Medicine, University of Liverpool, Liverpool, L69 3GA, UK.
Abstract
BACKGROUND: The prognosis of patients undergoing liver resection for colorectal liver metastases (CLM) seems to be altered when the primary tumour is right-sided. However, data are lacking and conflicting. We aimed to evaluate the influence of the primary tumour location on oncologic outcomes following such surgery. METHODS: We retrospectively analysed prospectively collected data from 376 consecutive patients who underwent liver surgery for CLM between June 2010 and August 2015. We compared the outcomes of patients with right colon tumours and those with left colorectal tumours. The splenic flexure was used as the cut-off point to determine the anatomic primary site. RESULTS: Among the 364 patients eligible, 74 (20.3%) had a right-sided primary tumour. These patients were older, had a poorer American Society of Anaesthesiologists status and had fewer node-positive primary tumours. The CLM characteristics were similar between both groups. Median PFS was not significantly different between the two groups at 9.9 months, as well as the pattern of recurrence. Median OS was shorter for patients with right-sided primary tumour (34.6 versus 45.3 months, p = 0.035). Similar results were observed when patients with rectal tumour were excluded from analysis (34.6 vs. 47.5 months, p = 0.007). Primary tumour site was an independent prognosis factor in multivariate analysis. CONCLUSION: Right-sided location of the primary tumour is associated with worse OS after surgery for CLM, but seems to have no influence on PFS, and on the pattern of recurrence.
BACKGROUND: The prognosis of patients undergoing liver resection for colorectal liver metastases (CLM) seems to be altered when the primary tumour is right-sided. However, data are lacking and conflicting. We aimed to evaluate the influence of the primary tumour location on oncologic outcomes following such surgery. METHODS: We retrospectively analysed prospectively collected data from 376 consecutive patients who underwent liver surgery for CLM between June 2010 and August 2015. We compared the outcomes of patients with right colon tumours and those with left colorectal tumours. The splenic flexure was used as the cut-off point to determine the anatomic primary site. RESULTS: Among the 364 patients eligible, 74 (20.3%) had a right-sided primary tumour. These patients were older, had a poorer American Society of Anaesthesiologists status and had fewer node-positive primary tumours. The CLM characteristics were similar between both groups. Median PFS was not significantly different between the two groups at 9.9 months, as well as the pattern of recurrence. Median OS was shorter for patients with right-sided primary tumour (34.6 versus 45.3 months, p = 0.035). Similar results were observed when patients with rectal tumour were excluded from analysis (34.6 vs. 47.5 months, p = 0.007). Primary tumour site was an independent prognosis factor in multivariate analysis. CONCLUSION: Right-sided location of the primary tumour is associated with worse OS after surgery for CLM, but seems to have no influence on PFS, and on the pattern of recurrence.
Authors: Cristian D Valenzuela; Omeed Moaven; Rohin Gawdi; John A Stauffer; Nico R Del Piccolo; Tan To Cheung; Carlos U Corvera; Andrew D Wisneski; Charles Cha; Christopher W Mangieri; Nima P Zarandi; Justin Dourado; Kathleen C Perry; Gregory Russell; Perry Shen Journal: HPB (Oxford) Date: 2022-02-28 Impact factor: 3.842
Authors: Vladislav Treska; Martin Skala; Kristyna Prochazkova; Aneta Svejdova; Tereza Petrakova; Jakub Sebek; Ivan Riha; Jachym Rosendorf; Robert Polak; Tomas Skalicky; Vaclav Liska Journal: In Vivo Date: 2020 Sep-Oct Impact factor: 2.155
Authors: Elisabeth Gasser; Eva Braunwarth; Marina Riedmann; Benno Cardini; Nikolaus Fadinger; Jaroslav Presl; Eckhard Klieser; Philipp Ellmerer; Aurélien Dupré; Katsunori Imai; Hassan Malik; Hideo Baba; Hanno Ulmer; Stefan Schneeberger; Dietmar Öfner; Adam Dinnewitzer; Stefan Stättner; Florian Primavesi Journal: PLoS One Date: 2019-05-31 Impact factor: 3.240
Authors: Ingrid Garajova; Rita Balsano; Chiara Tommasi; Raffaele Dalla Valle; Giuseppe Pedrazzi; Matteo Ravaioli; Andrea Spallanzani; Francesco Leonardi; Chiara Santini; Francesco Caputo; Mattia Riefolo; Mario Giuffrida; Fabio Gelsomino Journal: Acta Biomed Date: 2020-12-01
Authors: Mohammad Adileh; Jonathan B Yuval; Henry S Walch; Walid K Chatila; Rona Yaeger; Julio Garcia-Aguilar; Nikolaus Schultz; Philip B Paty; Andrea Cercek; Garrett M Nash Journal: Ann Surg Oncol Date: 2020-08-25 Impact factor: 5.344